학술논문
Health-Related Quality of Life (HRQoL) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) Who Are Triple-Class Exposed to an Immunomodulatory Agent, a Proteasome Inhibitor, and an Anti-CD38 Antibody
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:13259-13261
Subject
Language
ISSN
0006-4971